system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, METHODS, RESULTS. Meshes: 17-alpha-Hydroxyprogesterone, Adolescent, Androstenedione, Anti-Mullerian Hormone, California, Child, Chorionic Gonadotropin, Dehydroepiandrosterone, Female, Fertility Agents, Female, Humans, Injections, Intravenous, Polycystic Ovary Syndrome, Recombinant Proteins, Reproducibility of Results, Testosterone, Virginia.
user
Are 17-Hydroxyprogesterone responses to human chorionic gonadotropin associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome? Context: In adult women with polycystic ovary syndrome (PCOS) 17-OHP responses to human chorionic gonadotropin (hCG) stimulation are highly variable and inversely correlated with serum anti-Mullerian hormone (AMH) levels. The objective of this study was to determine whether adolescents with PCOS exhibit similar variable 17-OHP responsiveness to hCG and whether these responses are correlated to AMH levels. In a prospective study, adolescent PCOS (n=14) and normal controls (n=10) received 25 μg of hCG, intravenously. Blood samples were obtained before and 24 h afterwards for measurement of 17-OHP and basal AMH. Variable 17-OHP responses to hCG were observed among PCOS girls similar to that observed in adults. There was no correlation between AMH and 17-OHP responses to hCG.
assistant
Among adult and adolescent individuals with PCOS variable 17-OHP production appears to be characteristic of the disorder. In adolescent PCOS, 17-OHP responsiveness to hCG is not correlated to AMH. Final Decision: no